Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

ASCO 2025 will showcase cutting-edge advancements in precision medicine, artificial intelligence, and biomarker-driven ...

FluoGuide A/S ("FluoGuide" or the "Company") today releases its results for the period 1 January - 31 March 2025. The Q1 report is available as an attached document to ...

An EMR-based prompt significantly boosted molecular testing rates and detection of actionable mutations in early-stage, ...

Gene delivery systems can target specific brain cells, a breakthrough that could lead to treatments for Parkinson's, ...

Lyfgenia was FDA-approved in 2023 but costs $3.1 million per treatment, which could make access to the treatment difficult. The vaccine works by "targeting genetic mutations found in pancreatic ...